Home > Care & Treatment > Clinical Trials > Clinical Trials Search Results
The Young Women's Breast Cancer Study
For patients with 1-3 positive nodes, hormone receptor positive and HER2 negative breast cancer with recurrence score (RS) of 25 or less.
This registry is for individuaols who are newly diagnosed with MDS or AML. A bone marrow biposy must be done within 60 days of joining.
To help establish which treatments are effective in the treatment of Multiple Myeloma. This is a data registry and not a clinical trial that requires specific treatment regimes.
Phase II trial of combination Plerixafor (AMD3100), Bortezomib & Dexamethasone in relapsed or relapsed/refractory multiple myeloma.
Comparing conventional dose treatment using lenalidomide, bortezomib and dexamethasone (RVD) to high dose treatment with peripheral stem cell transplant.
A Phase II study of modified Lenalidomide, Bortezomib and Dexamethasone for Transplant Ineligible patients with newly diagnosed multiple myeloma.
Women > 65 years who are candidates for surgery
A Phase III Trial of Short Term Androgen Deprivation with Pelvic Lymph Node or Prostate Bed Only Radiotherapy (SPPORT).
Androgen deprivation therapy and high dose radiotherapy in unfavorable intermediate or favorable high risk prostate cancer.
Cape Cod Hospital 27 Park Street Hyannis MA 02601 Phone: 508-771-1800 Directions
Falmouth Hospital 100 Ter Heun Drive Falmouth, MA 02540 Phone: 508-548-5300 Directions
© 2015 Cape Cod Healthcare Inc.